Whitehawk Therapeutics (WHWK) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Whitehawk Therapeutics (WHWK) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Whitehawk Therapeutics

· WHWK

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

212.644 M

+0.80%

General

Market Cap: $212.64M
Enterprise Value: $129.12M
Shares Outstanding: 53,780,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -41.15%
ROE: -53.89%
ROIC: -47.05%
Current Ratio: 17.38
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 1.17
EV/EBITDA: -1.59

Growth

Rev 1Y: -72.50%
Rev 1Y Fwd Est: 23.56%
Rev 3Y (CAGR): -22.27%
Rev 5Y (CAGR): -13.29%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $86.06M
Operating Income: -$86.06M
Net Profit: -$79.83M

Balance Sheet

Cash and Equivalents: $85.23M
Working Capital: $181.35M
Total Assets: $193.99M
Net Debt: -$85.23M
Total Liabilities: $11.07M
Total Equity: $182.93M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$69.35M
Cash Flow from Investing: -$72.22M
Cash Flow from Financing: $81.87M
Free Cash Flow: -$69.35M
Capital Expenditures: $0